ROS, MAP, MARS, Clinical Core, LATC
|0||(no) if participant was not taking an antineoplastic medication at this visit|
|1||(yes) if participant was taking an antineoplastic medication at this visit|
Participants supplied all medications prescribed by a doctor, vitamins, supplements, and over-the-counter remedies and medicines taken in the 2 weeks prior to the evaluation. Direct visual inspection of all containers of prescription and over-the-counter agents allowed for medication documentation. Medications were subsequently coded using the Medi-Span Drug Data Base system.
TAMOXIFEN ARIMIDEX CASODEX NOLVADEX HYDROXYUREA TAMOXIFEN CYTOXAN FEMARA HYDREA LUPRON FLUTAMIDE LUPRON DEPOT GLEEVEC LEUCOVOR CA CARBOPLATIN AVASTIN RITUXAN BICALUTAMIDE ZOLADEX EULEXIN CISPLATIN
Medi-Span. Master Drug Data Base Documentation Manual. Indianapolis, IN: Medi-Span, 1995.